Neurology & Pain Renal Dosing by Creatinine Clearance
12 agents · renal dose adjustment
Renal dose adjustment for neurology & pain by creatinine clearance: each drug's cutoff, key caution, and the estimate its label uses.
Medically reviewed by Dr. Rishi Kumar Kafle, MBBS, MD, FASN. Last reviewed October 2026.

This chart covers renal dose adjustment for the 12 neurology & pain in this registry: Baclofen, Codeine, Duloxetine, Gabapentin, Levetiracetam, Lithium, Memantine, Meperidine, Morphine, Pregabalin, Topiramate and Tramadol. Of these, 11 are dosed by creatinine clearance from Cockcroft-Gault; and 1 has no CrCl dose band (Meperidine). Each drug links to its own page with the full threshold, cautions, and an FDA-label reference.
Reviewed and approved by Dr. Rishi Kumar Kafle, MBBS, MD, FASN. Always confirm against the label.
Neurology & Pain: renal dosing chart
| Drug | Renal estimate | Dose adjustment | Key caution |
|---|---|---|---|
| Baclofen | creatinine clearance (Cockcroft-Gault) | Reduce; avoid / very low <30 | encephalopathy |
| Codeine | creatinine clearance (Cockcroft-Gault) | <50 -> reduce; avoid <10 | metabolite accumulation |
| Duloxetine | creatinine clearance (Cockcroft-Gault) | Avoid <30 | See label |
| Gabapentin | creatinine clearance (Cockcroft-Gault) | <60 reduce; <30 daily; <15 lower | sedation/falls |
| Levetiracetam | creatinine clearance (Cockcroft-Gault) | Reduce by CrCl bands | See label |
| Lithium | creatinine clearance (Cockcroft-Gault) | Reduce; avoid in significant CKD; level-guided | toxicity; nephrotoxic |
| Memantine | creatinine clearance (Cockcroft-Gault) | <30 -> 5 mg BID max | See label |
| Meperidine | no renal estimate (no adjustment) | Avoid in CKD | normeperidine seizures |
| Morphine | creatinine clearance (Cockcroft-Gault) | <50 -> reduce | M6G metabolite accumulation |
| Pregabalin | creatinine clearance (Cockcroft-Gault) | Reduce dose by CrCl (<60) | sedation |
| Topiramate | creatinine clearance (Cockcroft-Gault) | <70 -> 50% | See label |
| Tramadol | creatinine clearance (Cockcroft-Gault) | <30 -> q12h, max 200 mg/day | seizure; serotonergic |
Cutoffs That Change Neurology & Pain Doses
The rules above name 6 creatinine clearance cutoffs, from 70 down to 10 mL/min. Each line lists the drugs whose rule changes at that value:
- 70 mL/min: Topiramate
- 60 mL/min: Gabapentin and Pregabalin
- 50 mL/min: Codeine and Morphine
- 30 mL/min: Baclofen, Duloxetine, Gabapentin, Memantine and Tramadol
- 15 mL/min: Gabapentin
- 10 mL/min: Codeine
Rules without a numeric renal-function cutoff: Levetiracetam, Lithium and Meperidine. Read their full rule in the chart and on each drug page. A cutoff that sits between two bands still needs the label wording, because some labels use "less than" and others "at or below" the value.
Worked Example: Neurology & Pain at a CrCl of About 49 mL/min
A 70-year-old man weighing 70 kg with a serum creatinine of 1.4 mg/dL has a Cockcroft-Gault creatinine clearance of about 49 mL/min. The rules to check first are those with a numbered step above that value: Codeine (50 mL/min), Gabapentin (60 mL/min), Morphine (50 mL/min), Pregabalin (60 mL/min) and Topiramate (70 mL/min). The numbered steps of Duloxetine (30 mL/min), Memantine (30 mL/min) and Tramadol (30 mL/min) sit lower, so they matter as clearance falls further. Baclofen, Levetiracetam and Lithium name a reduction that is not tied to a single CrCl cutoff, so read the full rule at any clearance.
How the Neurology & Pain Cutoffs Compare With the Standard Bands
Many renally cleared drugs follow four broad creatinine clearance bands: above 50, 30-50, 15-30, and below 15 mL/min. Of the 6 CrCl cutoffs named in this class, 3 sit on a standard band edge (50, 30 and 15 mL/min) and 3 do not (70, 60 and 10 mL/min), so the generic bands are only a rough guide for neurology & pain. Where a drug's own cutoff and the generic band disagree, the drug's cutoff takes precedence.
Avoidance, Dialysis and Monitoring Notes
- Avoid or contraindicated: Baclofen (avoid / very low <30); Codeine (avoid <10); Duloxetine (Avoid <30); Lithium (avoid in significant CKD); Meperidine (Avoid in CKD).
- Dialysis: no neurology & pain rule here mentions dialysis, so take dialysis dosing from each label.
- Levels and monitoring: Lithium (level-guided).
Which Renal Estimate the Labels Use for Neurology & Pain
Apply these thresholds to Cockcroft-Gault creatinine clearance in mL/min from the creatinine clearance calculator, because the labels were written against that estimate. eGFR in mL/min/1.73m² is a different quantity; see CrCl vs eGFR.
Where These Thresholds Come From
The 12 rules for neurology & pain were compiled from the FDA label (6 drugs), the Pharmacy Times renal dosing reference (4 drugs), FPnotebook (3 drugs) and standard clinical pharmacology references (2 drugs). Thresholds cross-checked against the FDA label or a guideline source: Gabapentin and Pregabalin. Every value has been reviewed by a clinician, and each drug page links its label through DailyMed.
How Reduced Kidney Function Affects Neurology & Pain
Renal impairment slows the elimination of neurology & pain and of any active metabolites the kidney clears. It also shifts the balance of benefit and harm, so dose-related adverse effects become more likely at the same nominal dose. The chart above gives the key caution for each agent. When one agent must be avoided below a cutoff, another in the class may be safer, so weigh the indication, the patient's trajectory, and monitoring availability. Record the estimate, the equation, the weight, and the date behind each dose, and re-estimate once a changing creatinine settles.
Calculate the Patient's CrCl First
Estimate creatinine clearance with the Cockcroft-Gault equation and the right dosing weight. Use actual body weight when it is below ideal body weight, ideal body weight up to 130% of ideal, and adjusted body weight above 130% of ideal, as in obesity. Re-estimate whenever kidney function may have changed, since acute illness and dehydration can lower clearance within days.
Related classes: Gout, GI, Oncology & Other renal dosing (gout, GI and oncology drugs with CrCl cutoffs).